APDN - Applied DNA Sciences Inc

APDN - Applied DNA Sciences Inc

https://www.adnas.com

Momentum: Bearish

Recent News

Powered by Alpha Vantage

Applied DNA to Resume Quarterly Investor Call Cadence Beginning with FQ3'25 Financial Results Report in Mid-August

Business Insider • 2 months, 4 weeks ago • score: -0.08

Applied DNA to Resume Quarterly Investor Call Cadence Beginning with FQ3'25 Financial Results Report in ...

Why Applied DNA Sciences ( APDN ) Stock Is Rising - Applied DNA Sciences ( NASDAQ:APDN )

Benzinga • 5 months, 1 week ago • score: 0.44

Applied DNA Sciences shares are trading higher by 18.7% during Tuesday's session. The company announced it positioned its TR8 PGx testing as pre-emptive testing for therapeutic safety. Learn how to trade volatility during Q1 earnings season, live with Matt Maley on Wednesday, April 2 at 6 PM ET. ...

Applied DNA Sciences ( APDN ) Reports Q1 Loss, Tops Revenue Estimates

Zacks Commentary • 7 months ago • score: 0.11

Applied DNA Sciences (APDN) delivered earnings and revenue surprises of -75% and 33%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

General Mills, Micron Technology And 3 Stocks To Watch Heading Into Wednesday - General Mills ( NYSE:GIS ) , Applied DNA Sciences ( NASDAQ:APDN )

Benzinga • 8 months, 4 weeks ago • score: 0.45

With U.S. stock futures trading higher this morning on Wednesday, some of the stocks that may grab investor focus today are as follows: Wall Street expects General Mills, Inc. GIS to report quarterly earnings at $1.22 per share on revenue of $5.14 billion before the opening bell, according to ...

Applied DNA Sciences ( APDN ) Reports Q4 Loss, Tops Revenue Estimates

Zacks Commentary • 8 months, 4 weeks ago • score: 0.10

Applied DNA Sciences (APDN) delivered earnings and revenue surprises of 3.03% and 1.63%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Interval:

EMA1: EMA2:

AI Tools

Key Metrics

Trend: Downtrend

Source: Snapshot

Applied DNA Sciences, Inc. develops and markets DNA-based technology solutions for use in the pre-clinical drug development and manufacturing markets based on nucleic acid-based in vitro diagnostics; and for supply chain security, anti-counterfeiting, and anti-theft technology applications in the United States, Europe, and Asia. The company is headquartered in Stony Brook, New York.

52W High

$1410.00

52W Low

$2.13

MA Status:

50D: Below 200D: Below

Beta (~1 neutral, <0.9 lower risk)

0.07

Valuation

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

N/A

Forward P/E (<15 better)

N/A

EV/EBITDA (<8 favorable)

-0.34

EV/Revenue (<3 favorable)

0.88

P/S (TTM) (<3 favorable)

0.83

P/B (<3 favorable)

0.17

Ownership

Retail‑heavy

Source: Overview

Insiders (1–5% typical)

1.11%

Institutions (25–75% balanced)

6.92%

Shares Outstanding

519,000

Float

1,291,400

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

3,743,100

Gross Profit (TTM)

1,250,900

EPS (TTM)

-57.12

Profit Margin (>10% good)

N/A

Operating Margin (TTM) (higher better)

-12.14%

ROE (TTM) (>15% strong)

-1.37%

EPS YoY (Quarterly) (>10% good)

N/A

Revenue YoY (Quarterly) (>8% good)

-0.36

Momentum

Bearish momentum

Value

-0.5632

Previous

-0.6006

Trend

Rising

Signal Cross

No cross

As of

Sep. 12, 2025